Imbed Biosciences
Developer and manufacturer of fully synthetic, bioresorbable polymer wound matrices designed to conform to wound beds and provide sustained antimicrobial activity. The company integrates antimicrobial silver and, in some products, topical lidocaine into ultra-thin synthetic matrices intended for acute, surgical, burn, and chronic wounds. It is registered with the U.S. FDA as a medical device establishment and maintains an ISO 13485:2016 certified quality management system.
Industries
Nr. of Employees
small (1-50)
Imbed Biosciences
Patents
Products
Synthetic antimicrobial wound matrix (bioresorbable polymer)
Ultra-thin, porous, synthetic wound matrix incorporating broad-spectrum antimicrobial silver, intended to conform to wound beds and resorb without removal; indicated for acute, surgical, burn, and chronic wounds.
Synthetic antimicrobial wound matrix with localized lidocaine
Matrix variant that integrates lidocaine HCl for localized topical pain management in addition to antimicrobial protection; includes dosing guidance and 24-hour lidocaine limits by body weight.
Device-specific usage guidance and quick-reference materials
Sell sheets, usage guidance documents, posters, and clinical detail aids tailored to product variants and clinical scenarios.
Synthetic antimicrobial wound matrix (bioresorbable polymer)
Ultra-thin, porous, synthetic wound matrix incorporating broad-spectrum antimicrobial silver, intended to conform to wound beds and resorb without removal; indicated for acute, surgical, burn, and chronic wounds.
Synthetic antimicrobial wound matrix with localized lidocaine
Matrix variant that integrates lidocaine HCl for localized topical pain management in addition to antimicrobial protection; includes dosing guidance and 24-hour lidocaine limits by body weight.
Device-specific usage guidance and quick-reference materials
Sell sheets, usage guidance documents, posters, and clinical detail aids tailored to product variants and clinical scenarios.
Services
Webinars, video interviews, live demonstrations, usage guidance documents, and conference presentations for healthcare providers.
Provision of posters, case studies, detail aids, and published references to support clinical decision making and product evidence.
Sales coordination, product demonstrations, and ordering assistance via direct contact with sales representatives.
Webinars, video interviews, live demonstrations, usage guidance documents, and conference presentations for healthcare providers.
Provision of posters, case studies, detail aids, and published references to support clinical decision making and product evidence.
Sales coordination, product demonstrations, and ordering assistance via direct contact with sales representatives.
Expertise Areas
- Synthetic biomaterials for wound care
- Antimicrobial wound dressing development
- Localized topical anesthetic delivery in dressings
- Clinical evidence generation and case-study support
Key Technologies
- Bioresorbable polymer matrices
- Silver-based antimicrobial integration
- Topical lidocaine formulation in matrices
- In vitro microbiological assays (simulated wound fluid)
News & Updates
Scheduled participation at a professional burn surgery forum for peer collaboration and presentation of wound care solutions.
Webinar discussing clinical experience and a 100-patient SSI-reduction study where a synthetic antimicrobial matrix was integrated into orthopedic protocols.
Webinar covering the dual-action approach combining antimicrobial matrix technology with lidocaine for pain relief.
Maintains an ISO 13485:2016 certified QMS for medical device manufacture.
Device listing and 510(k) summary cited for a lidocaine-containing wound dressing product (510(k) K211943).
CMS assigned HCPCS codes A2005 and A2040 to specific product variants to support billing identification.
Scheduled participation at a professional burn surgery forum for peer collaboration and presentation of wound care solutions.
Webinar discussing clinical experience and a 100-patient SSI-reduction study where a synthetic antimicrobial matrix was integrated into orthopedic protocols.
Webinar covering the dual-action approach combining antimicrobial matrix technology with lidocaine for pain relief.
Maintains an ISO 13485:2016 certified QMS for medical device manufacture.
Device listing and 510(k) summary cited for a lidocaine-containing wound dressing product (510(k) K211943).
CMS assigned HCPCS codes A2005 and A2040 to specific product variants to support billing identification.